Clinical and Genetic Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke.

BACKGROUND Stroke is a leading cause of death and disability worldwide. Atrial fibrillation (AF) is a common cause of stroke but may not be detectable at the time of stroke. We hypothesized that an AF polygenic risk score (PRS) can discriminate between cardioembolic stroke and noncardioembolic strokes. METHODS We evaluated AF and stroke risk in 26 145 individuals of European descent from the Stroke Genetics Network case-control study. AF genetic risk was estimated using 3 recently developed PRS methods (LDpred-funct-inf, sBayesR, and PRS-CS) and 2 previously validated PRSs. We performed logistic regression of each AF PRS on AF status and separately cardioembolic stroke, adjusting for clinical risk score (CRS), imputation group, and principal components. We calculated model discrimination of AF and cardioembolic stroke using the concordance statistic (c-statistic) and compared c-statistics using 2000-iteration bootstrapping. We also assessed reclassification of cardioembolic stroke with the addition of PRS to either CRS or a modified CHA2DS2-VASc score alone. RESULTS Each AF PRS was significantly associated with AF and with cardioembolic stroke after adjustment for CRS. Addition of each AF PRS significantly improved discrimination as compared with CRS alone (P<0.01). When combined with the CRS, both PRS-CS and LDpred scores discriminated both AF and cardioembolic stroke (c-statistic 0.84 for AF; 0.74 for cardioembolic stroke) better than 3 other PRS scores (P<0.01). Using PRS-CS PRS and CRS in combination resulted in more appropriate reclassification of stroke events as compared with CRS alone (event reclassification [net reclassification indices]+=14% [95% CI, 10%-18%]; nonevent reclassification [net reclassification indices]-=17% [95% CI, 15%-0.19%]) or the modified CHA2DS2-VASc score (net reclassification indices+=11% [95% CI, 7%-15%]; net reclassification indices-=14% [95% CI, 12%-16%]) alone. CONCLUSIONS Addition of polygenic risk of AF to clinical risk factors modestly improves the discrimination of cardioembolic from noncardioembolic strokes, as well as reclassification of stroke subtype. Polygenic risk of AF may be a useful biomarker for identifying strokes caused by AF.

[1]  A. Auton,et al.  Incorporating functional priors improves polygenic prediction accuracy in UK Biobank and 23andMe data sets , 2021, Nature Communications.

[2]  H. Kamel,et al.  Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial. , 2021, JAMA.

[3]  G. Breen,et al.  Evaluation of polygenic prediction methodology within a reference-standardized framework , 2020, bioRxiv.

[4]  Jeffrey M. Ashburner,et al.  Development and Validation of a Prediction Model for Atrial Fibrillation Using Electronic Health Records. , 2019, JACC. Clinical electrophysiology.

[5]  M. Pastore,et al.  Measuring Distribution Similarities Between Samples: A Distribution-Free Overlapping Index , 2019, Front. Psychol..

[6]  Brian E. Cade,et al.  Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program , 2019, Nature.

[7]  M. Rosenqvist,et al.  Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care , 2019, PloS one.

[8]  Naomi R. Wray,et al.  Improved polygenic prediction by Bayesian multiple regression on summary statistics , 2019, Nature Communications.

[9]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[10]  F. Hormozdiari,et al.  Disease heritability enrichment of regulatory elements is concentrated in elements with ancient sequence age and conserved function across species , 2018, bioRxiv.

[11]  Yang Ni,et al.  Polygenic prediction via Bayesian regression and continuous shrinkage priors , 2018, Nature Communications.

[12]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[13]  M. Salifu,et al.  Obstructive Sleep Apnea as a Risk Factor for Atrial Fibrillation: A Meta-Analysis , 2018, Journal of sleep disorders & therapy.

[14]  Henry J. Lin,et al.  Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation , 2017, Nature Genetics.

[15]  Henry J. Lin,et al.  Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation , 2017, Nature Genetics.

[16]  D. McManus,et al.  A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study. , 2016, American heart journal.

[17]  Francesca Pistoia,et al.  The Epidemiology of Atrial Fibrillation and Stroke. , 2016, Cardiology clinics.

[18]  P. Visscher,et al.  Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores , 2015, bioRxiv.

[19]  Joseph K. Pickrell,et al.  Approximately independent linkage disequilibrium blocks in human populations , 2015, bioRxiv.

[20]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[21]  P. Okin,et al.  Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis. , 2015, Annals of epidemiology.

[22]  H. Markus,et al.  Stroke Subtyping for Genetic Association Studies? A Comparison of the CCS and TOAST Classifications , 2013, International journal of stroke : official journal of the International Stroke Society.

[23]  Nancy R. Cook,et al.  Novel genetic markers improve measures of atrial fibrillation risk prediction , 2013, European heart journal.

[24]  A. Arboix,et al.  Cardioembolic Stroke: Clinical Features, Specific Cardiac Disorders and Prognosis , 2010, Current cardiology reviews.

[25]  Gregory Y H Lip,et al.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.

[26]  Euan A Ashley,et al.  Electrocardiographic predictors of atrial fibrillation. , 2009, American heart journal.

[27]  K. Muir,et al.  Secondary prevention of stroke , 2009, Expert review of cardiovascular therapy.

[28]  R B D'Agostino,et al.  Stroke severity in atrial fibrillation. The Framingham Study. , 1996, Stroke.

[29]  D. Levy,et al.  Impact of Left Ventricular Structure on the Incidence of Hypertension: The Framingham Heart Study , 1994, Circulation.

[30]  B. Murtagh,et al.  Cardioembolic stroke , 2006, Current atherosclerosis reports.